Skip to Navigation Skip to Main Content

Texas State Board of
Podiatric Medical Examiners

Physical Address: 333 Guadalupe, Suite #2-320; Austin, Texas 78701
Mailing Address: P.O. Box 12216; Austin, Texas 78711
Phone: (512)-305-7000
Facsimile: (512)-305-7003
www.tsbpme.texas.gov

Board Information
Compact With Texans
Complaints
Contact Us
Questions & Answers
License Verifications
Licensing
License Renewals
Radiology Technicians
Open Records
Statute & Rules
Continuing Education
General Information
Statewide Search
Employment Opportunities



Prescription Information

Please visit "Questions & Answers #4" which generally addresses the scope of practice for Podiatrists Writing Prescriptions.


Notice to all Controlled Substances Registration Registrants (Senate Bill 195 - 84th Session/2015). [Posted 08/12/2016 @ 4:52 pm]

Senate Bill 195 (84th Legislative Session; 2015), eliminates the requirement for a practitioner to have a Controlled Substances Registration with the State of Texas, effective Sept. 1, 2016. As the provisions of SB195 are implemented by the Texas State Board of Pharmacy throughout the coming months, this webpage will be revised and updated accordingly. Otherwise, SB195 has several key mandates:

  • The bill transfers the Texas Prescription Program (and the Ordering of Official Controlled Substances Prescription Pads) to the Texas State Board of Pharmacy from the Texas Department of Public Safety.

  • The bill eliminates the requirement for the Texas Department of Public Safety - Texas Controlled Substances Registration for those who manufacture, distribute, prescribe, possess, analyze, or dispense a controlled substance in this state. Prescribers will only need to hold a registration from the U.S. Drug Enforcement Administration (DEA).

  • The bill requires the Texas State Board of Pharmacy to establish a Prescription Drug Monitoring Program Database ("PMP AWARxE") for medical practitioners and state regulatory agencies (and requires the Texas Department of Public Safety to establish a separate secure Prescription Drug Monitoring Portal for law enforcement agencies).

  • Please contact the Texas State Board of Pharmacy to address any questions/requests related to SB195 and the new Texas Prescription Program, to include Ordering Official Controlled Substances Prescription Pads and Registering for the Prescription Drug Monitoring Program Database ("PMP AWARxE"). Additional details follow below.

Ordering Official Controlled Substances Prescription Pads from the Texas State Board of Pharmacy. Again, because the authority to issue prescription pads on/after September 1, 2016 is being transferred to the Texas State Board of Pharmacy, the Texas Department of Public Safety will not issue prescription forms after September 1, 2016. To ensure the orders received can be processed and the pads can be issued prior to September 1, 2016 the Texas Department of Public Safety will not process nor accept orders received after August 21, 2016. However, official prescription forms issued by the Texas Department of Public Safety prior to September 1, 2016 will be considered valid prescription forms. Official prescription pad orders received after August 21, 2016 by the Texas Department of Public Safety will be returned to the customer. On/after September 1, 2016 all prescription pads must be ordered from the Texas State Board of Pharmacy.

Texas Department of Public Safety - Texas Controlled Substances Registration Discontinued. Effective September 1, 2016 prescribers will no longer need a Controlled Substances Registration from the Texas Department of Public Safety; prescribers will only need to hold a registration from the U.S. Drug Enforcement Administration (DEA). Effective September 1, 2016 the Texas Department of Public Safety will discontinue accepting applications for the Texas Controlled Substances Registration under §481.061 of the Texas Health & Safety Code. Controlled Substances Registration applications received on/after September 1, 2016 by the Texas Department of Public Safety will be returned to the customer.

Registering for the New Prescription Drug Monitoring Program Database ("PMP AWARxE") at the Texas State Board of Pharmacy. Effective September 1, 2016, the "Prescription Access in Texas" (PAT) database hosted by the Texas Department of Public Safety will be discontinued and the New Appriss' "PMP AWARxE" Prescription Drug Monitoring Program Database hosted by the Texas State Board of Pharmacy goes live. "PMP AWARxE" is a secure online prescription monitoring program which will assist our Texas health care prescribing professionals in quickly identifying potential prescription drug abuse, patients who are "doctor shopping" or forging prescriptions and prescribers who are illicitly prescribing drugs. "PMP AWARxE" provides controlled substance prescription dispensing history to authorized medical practitioners and licensing board investigators. The Texas State Board of Pharmacy has created a Short Video announcing the new "PMP AWARxE" Prescription Drug Monitoring Program Database. As part of your Annual Texas Podiatry License Renewal Fee, "Active - Status" Texas Podiatrists will have already made the necessary payments to access the "PMP AWARxE" Prescription Drug Monitoring Program Database. However, in order to obtain access, "Active - Status" Texas Podiatrists must register with the Texas State Board of Pharmacy once the system goes live on September 1, 2016. The Texas State Board of Podiatric Medical Examiners strongly encourages all "Active - Status" Texas Podiatrists to register for and utilize the Texas State Board of Pharmacy's "PMP AWARxE" Prescription Drug Monitoring Program Database to combat all areas of prescription drug abuse. www.pharmacy.texas.gov/PMP/


Abuse/Misuse of Prescriptions/Pain Medications & Drug Diversion Prevention (SB144-78th; TOC §202.160). If you are a Podiatric Physician, please click on the following link to learn more about the Abuse/Misuse of Prescriptions/Pain Medications/Drug Diversion (SB144) in accordance with the provisions of Senate Bill 144 (effective January 1, 2004; 78th Texas Legislature). The informational site is graciously hosted through the efforts of the Texas State Board of Pharmacy.

For any other information regarding "Drug Diversion/Drug Abuse," "Prescription Scope of Practice Information," "Drug Rehabilitation," or to "Report Incidents of Drug Diversion/Substance Abuse/Physician Impairment," please contact Board staff.

"Drug Diversion" is a nationwide problem effecting physicians, patients and the general public. Proper distribution and receipt of "Controlled Substances" can not be achieved without proper regulation. The Board can assist anyone through open communication and reporting of those matters posing a risk to the public health, safety and welfare.

FDA News Release. For Immediate Release: July 9, 2012: "FDA introduces new safety measures for extended-release and long-acting opioid medications."

 

To report suspected "Prescription Fraud & Drug Diversion", contact the United States Drug Enforcement Administration (DEA) - Office of Diversion Control.


Prescribing Compounded Medications & Health Care Fraud.

Various providers prescribe compounded medications to treat their patient's ailments; provided that medical necessity, medical rationale and the standard of care for its use are evident for best patient outcomes.

The U.S. Food & Drug Administration (FDA) has additional "Compounding and the FDA: Questions and Answers" available on their website.

Kickbacks: A health care provider or other person engages in an illegal kickback scheme when he or she offers, solicits, pays, or accepts money, or something of value, in exchange for the referral of a patient for health care services that may be paid for by Medicare or Medicaid. A laboratory owner and doctor each violate the Anti-Kickback Statute when the laboratory owner pays the doctor $50 for each Medicare patient a doctor sends to the laboratory for testing. Although kickbacks are often paid in cash based on a percentage of the amount paid by Medicare or Medicaid for a service, kickbacks may take other forms such as jewelry, free paid vacations, or other valuable items.

Please visit "Questions & Answers #28" from the Board's website which addresses the overall nationwide problem of Health Care Fraud.

The patient's health and well-being must always take precedence over the business of medicine and the money that might be made in treating patients. Prescribers usually do not benefit monetarily when a prescription is written. The exception however is if the prescriber owns (or is a partial owner or investor) of a pharmacy or in some other way receives monetary value for writing a prescription. Kickbacks are illegal. The patient must be afforded the choice at which pharmacy to fill a prescription.

To report suspected "Medicare/Medicaid Fraud, Waste & Abuse" (to include "Federal Stark Law/False Claims Act/Anti-Kickback Statute/Physician Self-Referral Law") call toll free 1-800-HHS-TIPS (1-800-447-8477). This service is a product of the United States Department of Health & Human Services - Office of Inspector General.

To report "Texas Anti-Solicitation - Solicitation of Patients" complaints & "Deceptive Trade Practices" complaints, contact the Texas Attorney General's Office - Consumer Protection Division.


► Controlled Substances Schedule Changes.

♦ Hydrocodone - Schedule II. [Posted 09/06/2014 @ 6:00 pm] The Texas Department of Public Safety (DPS) is informing Texans that hydrocodone combination products (HCPs) have been moved from the classification of a Schedule III drug to the more-restrictive Schedule II drug, effective on Oct. 6, 2014.  The U.S. Drug Enforcement Administration’s rescheduling of HCPs as Schedule II controlled substances will increase the restrictions on prescribing and dispensing practices for hydrocodone combination drugs. HCPs are drugs that contain both hydrocodone – which by itself is a Schedule II drug – and specified amounts of other substances, such as acetaminophen or aspirin. The federal Controlled Substances Act places substances with accepted medical uses into one of four schedules, with the substances with the highest potential for harm and abuse being placed in Schedule II, and substances with progressively less potential for harm and abuse being placed in Schedules III through V.  (Schedule I is reserved for those controlled substances with no currently accepted medical use and lack of accepted safety for use.) See below.

  ▪ Click HERE for additional information on the U.S. Drug Enforcement Administration announcement.

  ▪ Click HERE for the 09/05/2014 DPS Press Release.

  ▪ Click HERE for the 08/21/2014 DEA Press Release.

  ▪ Click HERE for a 09/12/2014 DPS "Q&A Resulting from the Rescheduling of Hydrocodone". [Posted 09/13/2014 @ 8:02 pm]

Again, Hydrocodone Combination Products (HCPs) will be moving from a Schedule III controlled substance to the more-restrictive Schedule II, effective Oct. 6, 2014. The U.S. Drug Enforcement Administration’s (DEA) rescheduling of HCPs as Schedule II will increase restrictions on prescribing and dispensing practices for HCPs. In preparation for the DEA rescheduling of HCPs, the Texas Department of Public Safety (DPS) has increased staffing and resources to respond to medical practitioners needing assistance so they can better serve Texans who require prescriptions for HCPs. See below. [Posted 09/20/2014 @ 8:36 pm]

  ▪ Extended customer service availability from 7 a.m. to 7 p.m.

  ▪ Implemented an automated call back system allowing customers to make an appointment for an agent’s return call.

  ▪ Additional staff to help process registration modifications to allow practitioners to change their approved levels.

  ▪ Extended work hours for staff in both the Customer Contact Center and Order Fulfillment areas.

  ▪ Medical practitioners needing assistance can either call (512) 424-7293 or send a secured email.

  ▪ Medical and mid-level practitioners will need to have correct schedule designations on their registrations with DPS.

  ▪ Practitioners need to use NAR-116 and mid-level practitioners need to use NAR-117 to submit updates. 

  ▪ Prescription Pad Mail-in Order Forms are also on the DPS website.

  For more information, please see Hydrocodone: Schedule II Controlled Substance, DPS’ Press Release and DEA Announcement.

Tramadol - Schedule IV. [Posted 09/06/2014 @ 6:00 pm] DPS is also reminding Texans that tramadol is now a Schedule IV controlled substance as of Aug. 18, 2014. For more information, visit http://www.justice.gov/dea/index.shtml.